Total planned funding: $90,903,823
Allocations
Countries/Regions
| Asia Regional Program | $90,903,823 |
Organizational Types
| NGO | $27,071,345 |
| Own Agency | $25,141,678 |
| Unknown | $11,983,187 |
| University | $10,629,615 |
| Host Country Government Agency | $6,684,278 |
| Multi-lateral Agency | $5,585,608 |
| Private Contractor | $3,460,112 |
| Other USG Agency | $340,000 |
| Implementing Agency | $8,000 |
Program Areas
| Treatment | $23,488,262 |
| Governance and Systems | $21,831,020 |
| Management and Operations | $14,822,522 |
| Prevention | $13,582,422 |
| Testing | $10,043,667 |
| Care | $7,135,930 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $23,191,272 |
| HVMS: Management and Operations | $14,822,522 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,413,873 |
| OHSS: Health Systems Strengthening | $10,499,289 |
| HVCT: Testing: HIV Testing and Counseling | $10,043,667 |
| HVSI: Strategic Information | $8,435,601 |
| HBHC: Care: Adult Care and Support | $5,080,834 |
| HLAB: Laboratory Infrastructure | $2,896,130 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,701,778 |
| HKID: Care: Orphans and Vulnerable Children | $1,244,726 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $445,996 |
| PDCS: Care: Pediatric Care and Support | $432,110 |
| HVTB: Care: TB/HIV | $378,260 |
| HTXD: Treatment: ARV Drugs | $175,500 |
| PDTX: Treatment: Pediatric Treatment | $121,490 |
| HMBL: Biomedical Prevention: Blood Safety | $20,775 |
Top Partner Programs
U.S. Centers for Disease Control and Prevention:
$18,417,999
Countries/Regions
Asia Regional Program
| 2014 | $6,980,000 |
| 2020 | $11,437,999 |
U.S. Agency for International Development:
$6,640,679
Countries/Regions
Asia Regional Program
| 2014 | $1,060,480 |
| 2020 | $5,580,199 |